Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs
- 1 September 2014
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 189, 80-89
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science, ICT and Future Planning (NRF-2012R1A2A1A01007005, 2013K000264)
- Business for Cooperative R&D between Industry, Academy, and Research Institute (C0010962)
This publication has 32 references indexed in Scilit:
- Graphene and graphene oxide as new nanocarriers for drug delivery applicationsActa Biomaterialia, 2013
- Graphene: Promises, Facts, Opportunities, and Challenges in NanomedicineChemical Reviews, 2013
- Facile synthesis of water-dispersible Cu2O nanocrystal–reduced graphene oxide hybrid as a promising cancer therapeutic agentNanoscale, 2012
- New Horizons for Diagnostics and Therapeutic Applications of Graphene and Graphene OxideAdvanced Materials, 2012
- Nano-graphene in biomedicine: theranostic applicationsChemical Society Reviews, 2012
- Purified Graphene Oxide Dispersions Lack In Vitro Cytotoxicity and In Vivo PathogenicityAdvanced Healthcare Materials, 2012
- Minimizing Oxidation and Stable Nanoscale Dispersion Improves the Biocompatibility of Graphene in the LungNano Letters, 2011
- Successful Stabilization of Graphene Oxide in Electrolyte Solutions: Enhancement of Biofunctionalization and Cellular UptakeACS Nano, 2011
- Molecular Insights into the Surface Morphology, Layering Structure, and Aggregation Kinetics of Surfactant-Stabilized Graphene DispersionsJournal of the American Chemical Society, 2011
- High-Concentration, Surfactant-Stabilized Graphene DispersionsACS Nano, 2010